엠케이팜

비상장계속사업자

.

김봉관

Investment Review Report

Auto-filled from disclosures & public data + AI-drafted analysis. Edit, then export to PDF/DOCX.

Editor

1.Deal Terms

2.Valuation / Exit Assumptions

Exit Scenarios100M KRW

3.Fund Eligibility

Fund mandate eligibility — no data, enter manually

Enter fund mandate requirements and applicability (Y/N) to include a table in the report.

4.Capital Changes

Not in DART — enter capital-raise history manually

Enter capital changes such as founding capital and paid-in increases.

5.Stock Options

Enter manually

Enter stock option grant history.

6.Investment Highlights

AI draft — editable

Click 'Generate AI draft' to populate data-grounded investment highlights.

7.Investment Risks

AI draft — editable

Risks are populated after 'Generate AI draft'.

8.Market Analysis

AI draft — editable

9.Business Analysis

AI draft — editable

10.Conclusion (Investment Opinion)

AI draft — editable

11.P&L Projection

Analyst estimates, manual entry (100M KRW). Generates a trend chart & table.

Enter projected revenue / op. profit / net income (100M KRW) by year to add a trend chart and table.
Preview— the document below is saved as PDF/DOCX

Investment Review Report

엠케이팜

Business Reg. No. 2118709048 · CEO 김봉관

I.Investment Overview

Target엠케이팜 (2118709048)
Investment
Post-deal stake
ValuationPre — / Post —

II.Investment Highlights

No investment highlights written yet.

III.Investment Risks

No risks written yet.

IV.Company Profile

회사명엠케이팜
영문명.
대표자김봉관
사업자등록번호2118709048
법인등록번호1101112433649
설립일2002.01.28
종업원수5명

V.Workforce

5

Current headcount · 2026.06 as of

VI.Financial Summary

Per DART disclosure · in 억/만원 (KRW)

Financial trend (100M KRW)

매출액100M KRW28220212882022297.72023265.32024215.22025
영업이익100M KRW-11.82021-3.520220.42023-10.62024-10.12025
순이익100M KRW-2.720213.52022-3.22023-13.42024-1.32025
Item20252024202320222021
자산총계558.8억원542.4억원526억원508.9억원491.5억원
부채총계662.3억원644.6억원614.7억원594.5억원580.5억원
자본총계-103.5억원-102.2억원-88.8억원-85.5억원-89억원
매출액215.2억원265.3억원297.7억원288억원282억원
영업이익-10.1억원-10.6억원4,312만원-3.5억원-11.8억원
순이익-1.3억원-13.4억원-3.2억원3.5억원-2.7억원

VII.Financial Ratios

FY2025 basis

-4.7%

영업이익률

-0.62%

순이익률

-0.24%

ROA

ROE

부채비율

자기자본비율

VIII.Valuation & Exit Plan

Exit valuation
Holding period5y
Enter exit assumptions (investment, stake, exit valuation, period) to see MOIC·IRR.

This report compiles disclosure & public data and AI-drafts some sections as a research aid. It is not investment advice; the user bears final responsibility for facts and investment decisions.

엠케이팜 투심보고서 | Alpha Lenz